UTI COPY Flashcards

1
Q

Urinary tract infections

A
  • cystitis (acute uncomplicated, acute complicated, recurrent, interstitial cystitis)
  • Acute pyelonephritis
  • Acute prostatitis
  • Epididymitis
  • Urethritis (GC, NGU, Trichomoniasis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of acute cystitis

A

o Uncomplicated
Healthy nonpregnant women

o Complicated
Children
Elderly
Men 
Pregnancy 
Chronic medical conditions
Recurrent UTI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

UTI prevalence

A
o	50-60% of all women will experience a UTI
o	10% post-menopausal women
o	3% school-age girls
o	1% school-age boys
o	<1% adult men have uncomplicated UTI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of UTI

A

o Uropathogens from the fecal flora colonize the vaginal introitus
o Bacteria travel into the urethra and bladder and stimulate a host response
o May be facilitated by sexual intercourse
o Spermicides change the vaginal environment in favor of pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Protective physiology against UTIs

A
o	Micturition washes out most bacteria
o	Ureterovesical junctions close during micturition, preventing reflux of urine
o	Urine pH is bactericidal
o	Length of male urethra is prohibitive
o	Prostatic secretions are bactericidal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk factors for UTI

A
o	Female sex
o	Sexual activity
o	Diabetes = more sugar in the urine which means that you're more likely for bacteria to grow
o	Neurogenic (atonic) bladder
o	Urinary obstruction (i.e. BPH)
o	Kidney stones change the pH of the urine - higher pH
o	Vesicoureteral reflux
o	Indwelling urinary catheters
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Etiology of acute cystitis

A

o E. coli - 80-85%
o Staph saprophyticus 2nd most common
o Small number caused by Proteus, Klebsiella, enterococci, or other Gram negative bacteria
o Chlamydia may present as symptomatic UTI in some women
o Proteus is associated with kidney stones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical presentation of acute cystitis

A

o Dysuria
o Urinary frequency and/or urgency
o Urinary incontinence
o Suprapubic pain or pressure
o Hematuria
o Elderly patients many times don’t present with classical symptoms like younger adults do
o Hematuria - always ask if thy are menstruating
o Because of the irritation of the bladder, they feel like they have to pee all of the time
o acute onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnosis of acute cystitis

A
o	History, PE, Urinalysis
o	PE
     -Temp
     -Abdominal exam
     -CVA tenderness í leads you more to pyelonephritis
     -GU/pelvic exam if symptoms
o	You don't need to do a pelvic on everyone with a UTI
o	Strawberry cervix = trichomonas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Urinalysis for acute cystitis

A

o Midstream “clean catch” sample
o Leukocytes (pyuria), hematuria, nitrites
o Microscopic evaluation and culture usually not indicated
-Urine dipstick negative → Microscopic UA
-Casts indicate upper UTI
o UPT to rule out pregnancy
o Urine for GC/Chlamydia if suspected
o Nitrites are helpful because if you see them, then its probably E. coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment of uncomplicated acute cystitis

A

-Empiric treatment without microscopic UA or urine culture
-Nitrofurantoin; short course of SMP-TMX or a fluoroquinolone may be effective
-Depends on local resistance patterns and pt h/o recent abx use
-Pyridium 200mg po bid x 3 days prn dysuria
-Hydration; cranberry juice
-Can treat with Bactrim and sulfa
o All of these would be appropriate depending on your local resistance patterns
o SHORT COURSE - 3-5 days is usually enough for acute cystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

treatment of complicated acute cystitis

A

o Complicated acute cystitis
-Fluoroquinolone PO x 7-10 days
-Ceftriaxone 1g IM or IV qd x 7-10 days
o If no clinical improvement in 48 hours:
-Urine culture
-Consider alternate diagnosis
-Imaging studies: US, CT to rule out urinary tract pathology
o Can’t give quinolone to pregnant women í have to give ceftriaxone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Follow up for acute cystitis

A

o Repeat urine culture not usually needed
o Follow up only if patient does not improve or worsens
o Society Guidelines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Recurrent cystitis

A

o Common among women
o Relapse vs Reinfection
-Relapse: same infecting strain; infection within 2 weeks of treatment
-Reinfection: same infecting strain >2 weeks after treatment; or a different strain
-Vast majority are reinfections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

risk factors for recurrent cystitis

A

o Genetic component
-Nonsecretor, P1, and IL-8R phenotypes
-Mother with recurrent UTI
-Having first UTI before age 15 years
-If your mom and sisters and aunts get UTIs, you probably will too à there is a high probability you will too
o Frequent sexual intercourse
o Diaphragm-spermicide or condom with spermicide
o Urinary incontinence
o Cystocele
o Increased postvoid residual volume
-BPH
-Atonic bladder
o Vaginal/urethral atrophy
o Virulence determinants of uropathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Prevention strategies for recurrent cystitis

A

o Postcoital voiding
o Discontinue spermicide use
o Increased fluid intake (to increase micturition)
o Cranberry juice (unsweetened)
o Treatment of underlying issues (incontinence, atrophic vaginitis, etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Treatment of recurrent cystitis

A

o Antimicrobial prophylaxis
-Two or more symptomatic UTI within 6 months
-Three or more symptomatic UTI within 12 months
o Women are over 85% accurate in their own diagnosis of UTI
o Post-menopausal women
-Vaginal estrogen cream normalizes vaginal flora and can reduce recurrent UTI
o Lactobacilli
-Maintain low pH
-Produce bactericidal chemicals (H2O2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antimicrobial prophylaxis for recurrent cystitis

A

o Varying recommendations for length of prophylaxis
-6-12 months → increased rate of recurrence
->2 years
o Side effects of prophylaxis
-GI disturbance
-Oral and/or vaginal candidiasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Urology referral qualifications

A

o Recurrent UTI if suspect urogenital abnormality or complicated patients
o Persistent hematuria despite treatment
o Complicated UTI in males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Diagnostic studies

A
o	CT scan Abdomen &amp; Pelvis
o	Abdominal US - bladder pathology
o	Renal US - nephrolithiasis or obstruction
o	Cystoscopy
o	Voiding cystourethrogram
o	Urine cytology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

interstitial cystitis

A

o Syndrome of chronic or recurring bladder discomfort and/or pelvic pain in absence of other etiology
o Affects tissues of the lower urinary tract, pathology poorly understood
o Symptoms include urinary urgency, frequency, dysuria, nocturia, pubic/pelvic pain/pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Epidemiology of interstitial cystitis

A

o Common but prevalence not clear, probably 3%-6% women in USA
-Women 5x more likely than men
o Usually diagnosed in 4th decade of life
o Associated with other chronic pain syndromes
-Fibromyalgia, Irritable bowel syndrome, Vulvodynia
-Vulvodynia, fibromyalgia, IBS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

vulvodynia

A

vulvar discomfort, most often described as burning pain, occurring in the absence of relevant visible findings or a specific, clinically identifiable, neurologic disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

fibromyalgia

A

common cause of chronic musculoskeletal pain. It is one of a group of soft tissue pain disorders that affect muscles and soft tissues, such as tendons and ligaments. None of these conditions is associated with tissue inflammation and the etiology of the pain is not known.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

IBS

A

Irritable bowel syndrome (IBS) is a gastrointestinal syndrome characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause. It is the most commonly diagnosed gastrointestinal condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Interstitial cystitis pathophysiology theory - abnormal permeability

A

o Disruption in the urothelium and dysfunction of defense mechanisms
o Toxic compounds in urine (K+) penetrate protective layer of urothelium → activation of nerves and muscle tissue in the bladder
o Urothelial abnormalities in patients with IC/BPS include: altered bladder epithelial expression of HLA Class I and II antigens, decreased expression of uroplakin and chondroitin sulfate, altered cytokeratin profile, and altered integrity of the GAG layer. A defect in Tamm-Horsfall protein has been found in some patients. In addition, the expression of interleukin-6 and P2X3 ATP receptors is increased, and activation of the NFkB gene is enhanced.
o The GAG layer of the bladder normally coats the urothelial surface and renders it impermeable to solutes
o Antiproliferative factor (APF) may also have a pathogenetic role in the generation of IC/BPS symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

interstitial cystitis pathophysiology theory - neurologic upregulation

A

o Activation of sensory nerves in the bladder
o Neural activation may result from
-Peripheral nerve stimulation
-Injury from potassium
-Nerve regeneration
-Central activation of the sacral reflex arc
o Central sensitization and increased activation of bladder sensory neurons during normal bladder filling may result in bladder pain. Similar alterations in neural pathways may be responsible for the suprapubic tenderness that is present in IC/BPS patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

interstitial cystitis pathophysiology theory - mast cells and other mediators

A

o Mechanism and role not well understood
o Mast cell degranulation may cause symptoms
o Mast cells may be a response to the causative agent, contributing to the disease
o Other cell mediators present in IC may have roles as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

clinical presentation of interstitial cystitis

A

o Urinary urgency, frequency, bladder and/or pelvic pain most frequent symptoms
-Discomfort worsens with bladder filling, relieved with bladder emptying
o Insidious onset with gradual progression
-Usually 6 weeks to months or longer for diagnosis
-May be acute pain episodes or “flares”
o Symptoms may wax and wane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

differential diagnosis of interstitial cystitis

A
o	Dyspareunia
o	Overactive bladder
o	Recurrent UTI
o	Endometriosis
o	PID
o	Dysmenorrhea
o	Nephrolithiasis
o	Chronic pelvic pain
o	Urethral diverticulum
o	Vulvodynia
o	Chronic prostatitis
o	Prostatodynia
31
Q

diagnosis of interstitial cystitis

A

o Clinical - no clear diagnostic criteria; based on pt history and lack of alternative etiology
o PE: may be normal; variable anterior vaginal wall and bladder base tenderness
o By definition, all patients with IC/BPS have persistent unpleasant sensations that are attributable to the bladder. The duration of symptoms is at least six weeks.
o The location of the pain or discomfort is usually described as being suprapubic or urethral, although patterns such as unilateral lower abdominal pain or low back pain with bladder filling are observed.
o Regarding the onset of the symptoms, the majority of patients describe symptoms that are of gradual onset

32
Q

diagnostic evaluation of interstitial cystitis

A

o Urinalysis/Urine culture in all patients
o Chlamydia test in at-risk patients
o Urine cytolology/cystoscopy indicated if hematuria present
o Postvoid residual volume measured by urinary catheter or US if incontinence present
o Urodynamic Testing
-Not routinely recommended, no standard criteria
o The goal of the diagnostic evaluation for interstitial cystitis/bladder pain syndrome (IC/BPS) is to identify characteristic features and exclude other conditions.
o In certain patients in whom there is clinical uncertainty about the diagnosis, urodynamic testing can be helpful as part of the diagnostic process.

33
Q

Potassium sensitivity test

A

o Tests for abnormal urothelial permeability
o Not routinely recommended, not specific to IC
o The potassium sensitivity test has been proposed by some researchers as useful for diagnosis of IC/BPS, but is not recommended for routine use since its results are nonspecific for IC/BPS. Furthermore, the test can be extremely painful to the patients, and there is no consistent evidence that the results provide additional information to guide treatment above and beyond the standard diagnostic tests listed above.

34
Q

Cytoscopy and biopsy

A

o May show destructive changes of the mucosa
-Hunner lesions (red lesions on mucosa with attached fibrin deposits)
-Glomerulations (petechial areas)
-Increased mast cells on histology
o Indicated to exclude malignancy
o May be indicated in treatment failure
o Cystoscopy is not required to make the diagnosis of interstitial cystitis/bladder pain syndrome (IC/BPS), and is typically performed if other conditions are suspected initially or to further exclude other diagnoses if patients do not respond to treatment with oral medications. In addition, for patients who do not respond to initial therapy, cystoscopic treatment with hydrodistention or fulguration of intravesical lesions associated with IC/BPS may be beneficial.
o In some regions of the world, and historically in the United States, cystoscopy with bladder biopsy and hydrodistention are part of the routine evaluation of patients with suspected IC/BPS. The cystoscopic findings are used to classify patients into subgroups based upon the presence or absence of intravesical findings associated with IC/BPS. There is no evidence that subclassification of IC/BPS patients in this manner provides meaningful information about prognosis or treatment response.
o Evaluation with cystoscopy identifies Hunner lesions in only 5 to 10 percent of patients. For this subset of patients, fulguration of the lesions may help alleviate symptoms.
o Glomerulations are of limited diagnostic value, since they are a nonspecific finding

35
Q

treatment of interstitial cystitis

A

o Goal of therapy is symptom management
o pt edu and psychosocial support
-Self care: relaxation/stress reduction, support group
-Behavior modification: fluid management, timed voiding, avoid irritants
o Treat comorbid conditions
-UTI, incontinence, pelvic organ prolapse
-Depression/anxiety, other pain syndromes
o Pelvic floor PT for pts with pelvic floor pain
o Oral medications considered 2nd line therapy
o Tricyclic antidepressants (amitriptyline)-Inhibit neural activation
o Antihistamines-Control allergies that may aggravate disease-Control of mast cell degranulation?
o Analgesics are used for short-term relief for flares of bladder pain rather than as primary therapy.
o Intravesical lidocaine - rescue therapy

36
Q

acute pyelonephritis

A

o Infection of the upper urinary tract
o Most cases uncomplicated
o Chronic pyelonephritis is an uncommon cause of tubulointerstitial disease
“ Vesicoureteral Reflux
“ Chronic obstructing kidney stones
o Pregnancy, anatomic pathology, etc. complicate this

37
Q

epidemiology of acute pyelonephritis

A
o	Less common than cystitis
o	More common in females than males
o	Risk factors
"	Sexual activity >3 times per week or new partner; spermicide use
"	Previous UTI in the last 12 months
"	Diabetes 
"	Stress incontinence
38
Q

etiology of acute pyelonephritis

A

o E. coli in 70-95%
o Staph saprophyticus in 5-20%
o Proteus, Klebsiella, enterococci as well
“ Proteus: splitting of urease, alkalinizing the urine → struvite stones

39
Q

Pathophysiology of acute pyelonephritis

A

o Ascending uropathogens
o Asymptomatic or symptomatic cystitis precedes upper UTI
o Seeding of the kidneys from bacteremia via the lymphatics less common etiology

40
Q

clinical presentation of acute pyelonephritis

A
o	Flank pain
o	Fever >38°C
o	Nausea/vomiting
o	CVA tenderness
o	Frequency/urgency of urination
o	Dysuria 
o	Suprapubic pain
o	Fever > 101.5
o	Suprapubic pain is usually gone by this point but they definitely have flank pain
41
Q

diagnosis of acute pyelonephritis

A

o History & Physical Exam
“ Temp, Abdomen, CVA tenderness, Pelvic if indicated
“ UA and urine culture
“ (+/-) genital cultures
“ Blood cultures in pts requiring hospitalization
“ Imaging studies usually not needed

42
Q

urinalysis with microscopy for acute pyelonephritis

A

o Pyuria = white blood cells in the urine
o WBC casts indicate upper UTI
o Hematuria may be present; not specific
o Nitrite positive in Gram negative infections
o Urine C&S should be sent if pyelonephritis suspected because of potential serious sequelae

43
Q

treatment of acute pyelonephritis - uncomplicated, outpatient

A

o Fluoroquinolones or Aminoglycosides
“ High kidney tissue concentration of the drug
“ Low resistance levels
o May give first dose parenterally if patient is nauseated, and/or prescribe anti-emetics
o 10-14 days is sufficient in most patients
o Nitrofurantoin not effective for pyelo due to poor kidney tissue concentration.

44
Q

decision to admit acute pyelonephritis

A
o	Inability to maintain oral hydration
o	Inability to take oral medications
o	Concern about patient compliance
o	Uncertainty about the diagnosis
o	Severe illness with high fever, severe pain, debility
o	Complicated pyelonephritis infection
45
Q

Treatment of acute pyelonephritis - inpatient or complicated

A

o Ceftriaxone, Aminoglycosides or Fluoroquinolones
o Start with empiric treatment and tailor therapy with culture & sensitivity results
o Treat patient in the hospital until improved
“ Discharge on oral agents for 14 day course
o Kidney infections you need to treat longer (pyelo)
o Shorter course for acute cystitis

46
Q

follow up for acute pyelonephritis

A

o FU appt within 2 days in outpatients
o FU day after discharge for inpatients
o Routine post-treatment urine cultures not indicated unless complicated infection
o If symptoms do not resolve or recur within 2 weeks, further work-up is needed
“ UA, repeat C&S, CT scan or Renal US

47
Q

urology referral for acute pyelonephritis

A

o Patient does not improve within 72 hours of beginning treatment
o Recurrences of acute pyelonephritis
o Complicated or unstable patients

48
Q

indications for radiology - acute pyelonephritis

A
o	Symptoms of renal colic
o	Stone on X-Ray of the abdomen
o	Failure to improve within 72 hours of abx
o	Infection with unusual organism
o	Rapid relapse of infection
o	Men to r/o pathology
o	Children to r/o VUR
49
Q

Diagnostic evaluation of acute pyelonephritis

A
o	Abdominal X-Ray (flat &amp; upright - KUB)
"	Nephrolithiasis 
o	Renal ultrasound
"	Scarring, tumors, anatomic pathology
o	CT scan (the most sensitive)
o	DMSA radionuclide scanning (children)
o	Voiding cystourethrogram (Urologist)
50
Q

Imaging for acute pyelonephritis - occasional

A

o Ultrasound

o CT scan

51
Q

imaging for acute pyelonephritis - rare

A

o Nuclear scan (DMSA)

o Voiding cystourethrogram

52
Q

prostatitis

A

o Common problem in young and middle-aged men

o Symptoms include pelvic pain, bladder irritation, bladder outlet obstruction, hematospermia

53
Q

prostatitis classification

A

o I. Acute Prostatitis
o II. Chronic Bacterial Prostatitis
o III. Chronic Prostatitis/Pelvic Pain Syndrome
“ A. Inflammatory
“ B. Noninflammatory
o IV. Asymptomatic Inflammatory Prostatitis

54
Q

acute prostatitis

A

o Entry of microorganisms into the prostate gland via the urethra
o May be concomitant infection of bladder or epididymis
o Risk factors: trauma, dehydration, sexual abstinence or activity, urinary catheters, urethral strictures

55
Q

etiology of acute prostatitis

A
o	Gram negative bacteria most common
"	Enterobacteriaceae - E. coli, Proteus
o	Any uropathogens that cause UTI
"	Gonorrhea, Chlamydia
"	Staph species
"	Enterococcus
56
Q

clinical presentation of acute prostatitis

A

o Fever, chills, malaise, myalgia, dysuria, pelvic or perineal pain, cloudy urine
o Obstructive urinary symptoms: dribbling, urinary frequency/hesitancy
o Tender, edematous prostate on digital rectal exam
“ Be careful when doing DRE not to cause bacteremia

57
Q

laboratory evaluation of acute prostatitis

A
o	Urine culture
"	Pyuria and positive growth of organism
o	PSA may be elevated
o	CBC with leukocytosis (infection)
o	ESR, CRP often elevated (inflammation)
o	Occasionally blood cultures if patient is very ill and being admitted
o	PSA - prostate specific antigen
58
Q

treatment of acute prostatitis

A

o Antimicrobials tailored to culture results
“ Ampicillin 500mg po qid for enterococcus
“ Cephalexin 500mg po qid for Staph
“ Bactrim or fluoroquinolone for Gram neg rods
o NSAIDs
o Treat for 4-6 weeks
o FU urine culture in 1 week and again after treatment has been completed

59
Q

complications of acute prostatitis

A
o	Bacteremia
o	Epididymitis
o	Prostatic abscess
o	Chronic bacterial prostatitis
o	Complications are not common
o	Refer patients that are not improving
60
Q

epididymitis

A

o Common; inflammatory or infectious
o Acute, subacute, chronic
o Most commonly subacute infectious epididymitis in healthy young male
o Risk factors: sexual activity, heavy physical exertion, bicycle/motorcycle riding, recent urethral instrumentation

61
Q

infectious epidiymitis

A

o Acute - rare, serious illness
“ Fever, rigors, dysuria, frequency, urgency, scrotal pain
“ Secondary to UTI, especially prostatitis
o Subacute - common
“ Scrotal pain, no urinary symptoms
“ UA usually normal
o PE: epididymal induration and tenderness
o Chlamydia most common (also GC) esp in men <35 yo
o E. coli, coliforms, Pseudomonas in men >35 yrs or with anal intercourse

62
Q

treatment of infectious epididymitis

A

o Febrile, septic pts → hospital, IV abx
o Treat empirically while culture pending
“ Ceftriaxone 250mg IM x 1 + Doxycycline 100mg po bid x 10 days for most pts
“ Ofloxacin 300mg po bid or Levofloxacin 500mg po qd x 10 days for possible enteric organisms if low risk of GC/Chlamydia
o Ice, scrotal elevation/support, NSAIDs
o FU to ensure resolution

63
Q

noninfectious epididymitis

A

o Secondary to reflux of urine via ejaculatory ducts and vas deferens into epididymis → inflammatory response
o Treatment is conservative
“ Ice, scrotal elevation, NSAIDs, rest
“ Possibly antibiotics (doxycycline most often)

64
Q

urethritis

A

o Most common STI in males
o May occur in females with cervicitis
o Classified as gonoccocal (GU) or nongonococcal (NGU)
o 15-25% co-infection of Chlamydia trachomatis in patients with GC
o NGU 2.5 x more prevalent than GU in developed countries

65
Q

GC signs and symptoms

A

o Abrupt onset purulent d/c; dysuria; pelvic pain in females; 75% develop sx in 4d
“ Many patients may be asymptomatic
“ May have associated pharyngitis, conjunctivitis, etc
o Incubation 2-7 days

66
Q

GC diagnosis

A

o Preferred test is nucleic acid amplification: polymerase chain reaction (PCR)
“ Urine, urethral or cervical/vaginal swab
o Culture in selective growth medium
o Neiserria gonorrhea: gram negative intracellular diplococci
o Gram stains of urethral discharges are the most rapid method of diagnosing gonococcal urethritis.
o When gram-negative diplococci are visible within neutrophils, sensitivity of the Gram stain is:
“ 95% in the case of males with GC symptomatic urethritis
“ 60% for male asymptomatic urethritis
“ 40 to 70% for females with symptomatic cervicitis
o Specificity in each group is 95%

67
Q

disseminated gonorrhea

A
o	Occurs in 5% of untreated cases
o	Presents with 
"	fever
"	arthralgias
"	arthritis/tenosynovitis
"	skin rash (scattered pustular lesions or hemorrhagic blisters)
"	Septic joint
68
Q

GC treatment

A

o Increasing resistance to penicillin and tetracycline; high resistance to Cipro
o IM ceftriaxone 250 mg
“ Cefotaxime 500 mg IM; cefoxitin 2gm IM
o Treat presumptive urethritis for both GC and Chlamydia
o Tx partner! Pts should be instructed to avoid sexual contact for 7 days after tx
o Always test for cure
o Reportable to PHD
o ~75% of all GC organisms in the US are penicillin resistant

69
Q

NGU

A

o Chlamydia trachomatis is the most common pathogen - 30-50%
“ C trachomatis bacterium is an obligate intracellular parasite
o Other pathogens: herpes simplex, trichomoniasis, candida, mycoplasma, ureaplasma urealyticum

70
Q

NGU signs and symptoms

A
o	NGU:  insidious onset
o	50% develop sx in 4 d
o	Incubation 7-21 d
o	Less profuse mucoid urethral  d/c 
o	May have dysuria without urethral d/c 
o	Diagnosis by testing for C. trachomatis with DNA probe/PCR or genital culture for other pathogens
o	Ligase chain reaction
71
Q

Chlamydia tx

A

o Azithromycin 1 gm PO single dose
“ Doxycycline 100mg BID x 7 days
o Recurrent infection more common in NGU
o Treat presumptive urethritis for both GC and Chlamydia
o Tx partner! Pts should be instructed to avoid sexual contact for 7 days after tx
o Always test for cure
o Reportable to PHD

72
Q

Trichomoniasis

A

o Parasitic flagellate protozoa
o Prevalence closely linked to other STI’s
o Risk factors include sexual activity, pregnancy, menses
o Identified in 70% of male sexual partners of infected women

73
Q

Trichomoniasis tx

A

o Metronidazole: 2 grams single dose or 500mg po bid x 5-7 days
o Sexual partners should be treated

74
Q

Urethritis/vaginitis vs. acute cystitis

A

o Rule out urethritis/vaginitis caused by STI

 - Vaginal/penile discharge or odor, pruritis, dyspareunia
 - Lack of urinary frequency
 - New sexual partner or h/o STI
 - Partner has symptoms
 - Gradual onset of symptoms í not typical of acute cystitis, more typical of gonorrhea or chlamydia